Logo image of CIT

CIT Group Inc (CIT) Stock Fundamental Analysis

NYSE:CIT - New York Stock Exchange, Inc. - Common Stock

53.5  +2.16 (+4.21%)

After market: 53.82 +0.32 (+0.6%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CIT. CIT was compared to 397 industry peers in the Banks industry. CIT may be in some trouble as it scores bad on both profitability and health. CIT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CIT had positive earnings in the past year.
CIT Yearly Net Income VS EBIT VS OCF VS FCFCIT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 1B -1B 2B

1.2 Ratios

Industry RankSector Rank
ROA 1.31%
ROE 11.58%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CIT Yearly ROA, ROE, ROICCIT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 5 -5 -10

1.3 Margins

The Operating Margin and Gross Margin are not available for CIT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 28.46%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CIT Yearly Profit, Operating, Gross MarginsCIT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 20 -20 40

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, CIT has more shares outstanding
The debt/assets ratio for CIT has been reduced compared to a year ago.
CIT Yearly Shares OutstandingCIT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 50M 100M 150M 200M
CIT Yearly Total Debt VS Total AssetsCIT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 20B 40B 60B

2.2 Solvency

A Debt/Equity ratio of 0.69 indicates that CIT is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CIT Yearly LT Debt VS Equity VS FCFCIT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 5B 10B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

4

3. Growth

3.1 Past

CIT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 455.37%, which is quite impressive.
The Revenue has been growing slightly by 6.45% in the past year.
Measured over the past years, CIT shows a small growth in Revenue. The Revenue has been growing by 5.14% on average per year.
EPS 1Y (TTM)455.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.76%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y-0.98%
Revenue growth 5Y5.14%
Sales Q2Q%-6.18%

3.2 Future

CIT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.51% yearly.
The Revenue is expected to grow by 4.10% on average over the next years.
EPS Next Y359.06%
EPS Next 2Y86.6%
EPS Next 3Y53.57%
EPS Next 5Y25.51%
Revenue Next Year4.36%
Revenue Next 2Y0.45%
Revenue Next 3Y4.22%
Revenue Next 5Y4.1%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CIT Yearly Revenue VS EstimatesCIT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
CIT Yearly EPS VS EstimatesCIT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.51, which indicates a very decent valuation of CIT.
When comparing the Price/Earnings ratio of CIT to the average of the S&P500 Index (27.30), we can say CIT is valued rather cheaply.
With a Price/Forward Earnings ratio of 11.72, the valuation of CIT can be described as very reasonable.
CIT's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 8.51
Fwd PE 11.72
CIT Price Earnings VS Forward Price EarningsCIT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CIT Per share dataCIT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CIT's earnings are expected to grow with 53.57% in the coming years.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y86.6%
EPS Next 3Y53.57%

More info and screens

4

5. Dividend

5.1 Amount

CIT has a Yearly Dividend Yield of 2.73%. Purely for dividend investing, there may be better candidates out there.
CIT's Dividend Yield is comparable with the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 2.73%

5.2 History

The dividend of CIT is nicely growing with an annual growth rate of 31.91%!
CIT has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)31.91%
Div Incr YearsN/A
Div Non Decr YearsN/A
CIT Yearly Dividends per shareCIT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 0.2 0.4 0.6 0.8 1

5.3 Sustainability

23.91% of the earnings are spent on dividend by CIT. This is a low number and sustainable payout ratio.
CIT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP23.91%
EPS Next 2Y86.6%
EPS Next 3Y53.57%
CIT Yearly Income VS Free CF VS DividendCIT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 0 500M -500M 1B -1B -1.5B
CIT Dividend Payout.CIT Dividend Payout, showing the Payout Ratio.CIT Dividend Payout.PayoutRetained Earnings

More info and screens

CIT Group Inc

NYSE:CIT (1/3/2022, 8:04:00 PM)

After market: 53.82 +0.32 (+0.6%)

53.5

+2.16 (+4.21%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)N/A N/A
Earnings (Next)02-01 2022-02-01/bmo
Inst Owners0%
Inst Owner Change0%
Ins Owners2.6%
Ins Owner Change0%
Market Cap5.28B
Analysts49.09
Price Target53.65 (0.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.73%
Yearly Dividend1.4
Dividend Growth(5Y)31.91%
DP23.91%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.51
Fwd PE 11.72
P/S 2.1
P/FCF N/A
P/OCF N/A
P/B 0.85
P/tB N/A
EV/EBITDA N/A
EPS(TTM)6.29
EY11.76%
EPS(NY)4.56
Fwd EY8.53%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS25.47
BVpS62.62
TBVpSN/A
PEG (NY)0.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.31%
ROE 11.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 28.46%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)455.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.76%
EPS Next Y359.06%
EPS Next 2Y86.6%
EPS Next 3Y53.57%
EPS Next 5Y25.51%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y-0.98%
Revenue growth 5Y5.14%
Sales Q2Q%-6.18%
Revenue Next Year4.36%
Revenue Next 2Y0.45%
Revenue Next 3Y4.22%
Revenue Next 5Y4.1%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A